You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Watson Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?

WATSON LABS has one thousand and thirty-one approved drugs.

There are eighteen tentative approvals on WATSON LABS drugs.

Summary for Watson Labs

US Patents:	0
Tradenames:	399
Ingredients:	376
NDAs:	1031

Drugs and US Patents for Watson Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077890-003	Oct 14, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Watson Labs	MEPERIDINE HYDROCHLORIDE	meperidine hydrochloride	TABLET;ORAL	040186-001	Jun 30, 1997		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Watson Labs	HYDROCHLOROTHIAZIDE	hydrochlorothiazide	TABLET;ORAL	087002-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Watson Labs	METHYLDOPA AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; methyldopa	TABLET;ORAL	071923-001	Aug 29, 1988		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Watson Labs	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	081079-001	Aug 30, 1991		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Watson Labs	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	091129-001	Oct 6, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Watson Labs Teva	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET;ORAL	207588-009	May 10, 2022	AB1,AB2,AB3,AB4	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for WATSON LABS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.